A story about the Dog Aging Project entitled “The Drug That Could One Day Help People — and Dogs — Live Longer” was published in the popular science magazine Discover. The article covers the upcoming Trial of Rapamycin in Aging Dogs (TRIAD) clinical trial. Low doses of rapamycin have been shown to extend lifespan and healthy longevity in every model organism where it has been tested. It is predicted that rapamcyin will improve cardiac function, boost immune function, reduce or delay the risk of cancer, reverse periodontal aging and increase healthy lifespan of middle-aged dogs by two to five years.
The Dog Aging Project is co-directed by HALO Director Dr. Matt Kaeberlein and HALO Faculty member Dr. Daniel Promislow.
